Barbara Burtness named chief translational research officer at Yale

Roy Herbst elected to Friends board of directors

Roy S. Herbst, deputy director of Yale Cancer Center and Smilow Cancer Hospital and assistant dean for translational research at Yale School of Medicine, was elected to the Friends of Cancer Research Board of Directors.

January 12, 2024

Vol.50 No.02

In the Archives

Yale’s Richard Edelson on what got him started in research for cutaneous T-cell lymphoma

Richard Edelson began his career at NCI, where he was training to become a cancer immunologist.

October 27, 2023

Vol.49 No.40

Clinical Roundup

Yale scientists develop approach to strengthen CAR T cell therapy for cancer treatment

Using a new approach, Yale Cancer Center researchers at Yale School of Medicine found a new way to substantially improve the effectiveness of CAR-T cell therapy.

August 04, 2023

Vol.49 No.31

Clinical Roundup

Yale physicians using new technology to diagnose lung cancer

Yale Medicine physicians are using robotic bronchoscopy instead of traditional bronchoscopy for lung cancer diagnosis. Robotic bronchoscopy allows them to better reach smaller parts of the lungs. During a robotic bronchoscopy, the doctor uses a controller at a console to operate a robotic arm, which then guides the bronchoscope’s thin, flexible tube through the airways.

March 24, 2023

Vol.49 No.12

Clinical Roundup

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs 69

Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.

February 03, 2023

Vol.49 No.05

Clinical Roundup

Older patients left behind in progress against lung cancer, Yale study shows

Although widespread use of immune checkpoint inhibitors in patients with advanced lung cancer has led to meaningful improvements in survival in younger patients, older patients have not experienced similar survival benefits, new research from Yale Cancer Center shows.

February 03, 2023

Vol.49 No.05

Barbara Burtness named chief translational research officer at Yale

YOU MAY BE INTERESTED IN

Roy Herbst elected to Friends board of directors

Yale’s Richard Edelson on what got him started in research for cutaneous T-cell lymphoma

Yale scientists develop approach to strengthen CAR T cell therapy for cancer treatment

Yale physicians using new technology to diagnose lung cancer

Study finds large gap in breast cancer treatment recommendations for patients aged 70 vs 69

Older patients left behind in progress against lung cancer, Yale study shows

Renew today!

Subscriber content

Login